Spectral Med Correlations
| EDT Stock | CAD 0.53 0.03 6.00% |
The current 90-days correlation between Spectral Med and Medicenna Therapeutics Corp is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Spectral Med Correlation With Market
Good diversification
The correlation between Spectral Med and DJI is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Spectral Med and DJI in the same portfolio, assuming nothing else is changed.
Spectral |
The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
Moving against Spectral Stock
| 0.85 | WMT | Walmart Inc CDR | PairCorr |
| 0.77 | META | Meta Platforms CDR | PairCorr |
| 0.75 | TSLA | Tesla Inc CDR | PairCorr |
| 0.73 | AMZN | Amazon CDR | PairCorr |
| 0.71 | NVDA | NVIDIA CDR | PairCorr |
| 0.65 | TD-PFI | Toronto Dominion Bank | PairCorr |
| 0.63 | GOOG | Alphabet CDR | PairCorr |
| 0.57 | AVGO | Broadcom | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Spectral Stock performing well and Spectral Med Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spectral Med's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| HBP | 5.07 | (0.03) | 0.00 | 0.14 | 0.00 | 9.35 | 46.60 | |||
| APS | 3.58 | (1.07) | 0.00 | 1.47 | 0.00 | 5.66 | 34.00 | |||
| MBX | 1.28 | (0.23) | 0.00 | 0.79 | 0.00 | 2.94 | 8.04 | |||
| RVX | 3.78 | (0.32) | 0.00 | (0.14) | 0.00 | 16.67 | 34.29 | |||
| MDNA | 3.88 | (0.32) | 0.00 | 0.77 | 0.00 | 7.66 | 27.82 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Spectral Med without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Spectral Med Corporate Management
Elected by the shareholders, the Spectral Med's board of directors comprises two types of representatives: Spectral Med inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spectral. The board's role is to monitor Spectral Med's management team and ensure that shareholders' interests are well served. Spectral Med's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spectral Med's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sam Amory | Pres Inc | Profile | |
| BSc RN | VP Devel | Profile | |
| Blair McInnis | Chief Officer | Profile | |
| Christopher Seto | CEO Director | Profile | |
| John MD | Chief Officer | Profile |